Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
IOVA holding history
Iovance Biotherapeutics, Inc. in every 13F filed by Boxer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IOVA overviewAll 13F holders of IOVAFull Q4 2024 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −750,000−100.0% | Sold out | Holders |
| Q3 2024 | 750,000 | $7.04M | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2024 | 750,000 | $6.01M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2024 | 750,000 | $11.1M | 0.5% | −650,000−46.4% | Reduced | Holders |
| Q4 2023 | 1,400,000 | $11.4M | 0.6% | −2,305,133−62.2% | Reduced | Holders |
| Q3 2023 | 3,705,133 | $16.9M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2023 | 3,705,133 | $26.1M | 1.2% | 00.0% | Unchanged | Holders |
| Q1 2023 | 3,705,133 | $22.6M | 1.1% | +2,200,000+146.2% | Added | Holders |
| Q4 2022 | 1,505,133 | $9.62M | 0.5% | −430,000−22.2% | Reduced | Holders |
| Q3 2022 | 1,935,133 | $18.5M | 1.0% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,935,133 | $21.4M | 1.4% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,935,133 | $32.2M | 1.7% | +835,133+75.9% | Added | Holders |
| Q4 2021 | 1,100,000 | $21.0M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2021 | 1,100,000 | $27.1M | 0.9% | +1,100,000 | New | Holders |